Indian pharma takes 'wait-and-watch' approach to tackle Trump's 200% tariff plan | What next?

Donald Trump announced a plan to bring drug manufacturing back to the US, imposing zero tariffs on imported generics for two years, and then increasing them to 100% and 200%.

First seen 53m ago · latest update 53m ago · India · business

Developing: this story surfaced recently from a single outlet. It appears early by design — expect the confidence score to move as more outlets report (or don’t).